VR exposure therapy versus sertraline for social anxiety in teens
Official title: Comparison of the Effectiveness Level of Virtual Reality Exposure Therapy With Sertraline Treatment in Social Anxiety Disorder
Run by Kocaeli University · NCT07192367 · Data updated 2026-11-12
This study will test whether virtual reality exposure therapy or the medication sertraline works better for adolescents aged 12–17 with social anxiety.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 12 Years to 17 Years |
| Sex | All |
| Enrollment | 56 (estimated) |
| Sponsor | Kocaeli University Academic / other |
| Locations | 1 site (Kocaeli) |
| Status | Recruiting |
| Started | November 15, 2024 |
| Main results expected | August 2026 |
| Study ends | December 2026 |
| Registry record updated | September 25, 2025 |
| Trial ID | NCT07192367 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are 12–17-year-olds diagnosed with social anxiety disorder, not currently on psychiatric medication, with normal intelligence and who can provide informed consent with guardian approval.
✕Probably not a fit
Patients with severe comorbid psychiatric or medical conditions, intolerance to SSRIs, or those who cannot tolerate VR (for example due to motion sickness or epilepsy) may not benefit from the interventions tested here.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-site, preference-allocated study at Kocaeli University will enroll 56 adolescents and young people with diagnosed social anxiety disorder and compare two treatment approaches: therapist-led virtual reality exposure sessions using a headset, and oral sertraline medication. Participants choose the treatment they prefer and then receive that intervention according to standardized protocols over the study period. The primary outcome is reduction in social anxiety symptoms using validated clinical scales, with secondary outcomes including daily functioning, treatment acceptability, and safety measures. The goal is to determine whether VR exposure can be an effective and acceptable alternative to pharmacological treatment in this age group.
Why it matters
Potential benefit: If successful, the study could show that VR exposure offers an effective non-drug option that reduces social anxiety and may be more acceptable to some adolescents and families.
How similar studies have gone: Prior research shows sertraline and other SSRIs are established treatments for social anxiety and VR exposure therapy has shown promising results in adults and adolescents, though VR is less extensively studied in youth than medication.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * RESEARCH ARM: 1. Applied to Kocaeli University Child and Adolescent Psychiatry Outpatient Clinic 2. Have normal intelligence based on clinical observation 3. Be between 12 and 17 years of age 4. Have a diagnosis of SAD 5. Have refused medication recommended for SAD 6. For SAD; are not currently receiving medical treatment 7. Have received written consent to participate in the study from them and/or their first-degree relatives authorized to make decisions about them 8. Have volunteered to participate in the study through an invitation poster presentation CONTROL ARM: 1 Applied to Kocaeli University Child and Adolescent Psychiatry Outpatient Clinic 2. Have normal intelligence based on clinical observation 3. Be between 12 and 17 years of age 4. Have a diagnosis of SAD 5. Have refused medication recommended for SAD 6. For SAD; are not currently receiving medical treatment 7. Have obtained written informed consent to participate in the study from them and/or their first-degree relatives authorized to make decisions about them 8. Have volunteered to participate in the study through an invitation poster presentation CONTROL ARM: 1 Applied to Kocaeli University Child and Adolescent Psychiatry Outpatient Clinic 2. Have normal intelligence based on clinical observation 3. Be between 12 and 17 years of age 4. Have a diagnosis of SAD 5. For SAD; Not currently receiving medical treatment 6. Volunteer 7. Written consent for participation in the study must be obtained from the patient and/or their first-degree relative authorized to make decisions about them. 8\. Accept sertraline treatment, routinely used in outpatient clinic follow-ups for SAD, and volunteer for the study. Exclusion Criteria: RESEARCH ARM: 1. Substance use disorder 2. Schizophrenia and bipolar disorder 3. Autism spectrum disorder 4. Cognitive disability 5. Neurological disorder 6. Balance disorder 7. Patients who have received SSRI treatment for SAD in the last 6 months CONTROL ARM: 1. Substance use disorder 2. Schizophrenia and bipolar disorder 3. Autism spectrum disorder 4. Cognitive disability 5. Patients who have received SSRI treatment for SAD within the last 6 months -
Where it's running
-
Kocaeli University Hospital - Department of Child and Adolescent Psychiatry
Kocaeli, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Nursu Çakın Memik, MD, Prof. — Kocaeli University, Department of Child and Adolescent Psychiatry
- Study coordinator: Emine Kayış, MD
- Email: eminekanmaz@gmail.com
- Phone: +905557452890
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Anxiety Skills Study: See if video skill training plus therapy helps people with anxiety
This study tests whether a brief video-based skill training can help people with anxiety as well as four therapy sessions, and how durable the effects are over a year.
-
taVNS Therapy for Social Anxiety Disorder
This study tests whether non-invasive taVNS can help reduce social anxiety symptoms in adults with SAD.
-
Metacognitive Therapy vs Cognitive-Behavioral Therapy for Anxiety Disorders
This study asks people with generalized anxiety disorder, social anxiety disorder, or PTSD to share their experiences after trying metacognitive therapy or disorder-specific cognitive-behavioral therapy in a randomized trial.
-
Mindful Self-Compassion delivered in person versus by video for anxiety and depression
This project will see if an 8-week Mindful Self-Compassion class delivered in person or by video helps people with anxiety or depression have fewer symptoms.
-
Stepped versus stratified care for anxiety in children and adolescents
This project tests whether starting all 8–17-year-olds with anxiety on online CBT and adding in-person CBT only if needed (stepped care) works as well as assigning online or in-person CBT up front based on clinical complexity (stratified care).
-
Team-delivered exposure-based CBT for children and teens with anxiety and OCD
This test tries three ways of delivering team-based exposure-focused CBT—in-person, by telehealth, or a flexible mix—to see which works best for kids and teens (ages 5–18) with anxiety or OCD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.